India records over 2.81 lakh new COVID-19 cases, 4,106 fatalities in 24 hours

New Delhi: India recorded over 2.81 lakh new COVID-19 circumstances and 4,106 fatalities in the final 24 hours, as per the Union Health Ministry on Monday (May 17, 2021) morning.

According to the official information, there have been 2,81,386 new infections, which took the nation’s whole caseload to 2.49 crore. India now has 35,16,997 lively COVID-19 circumstances.

The nation’s coronavirus-related demise toll has now elevated to 2,74,390, whereas the entire variety of recoveries has crossed 2.11 crore. 

This is to be famous that Karnataka, Maharashtra, Tamil Nadu and Kerala have been the worst affected states by the second wave of coronavirus. 

Earlier on Sunday, there have been 3,11,170 new COVID-19 circumstances and 4,077 deaths in India.

Union Health Secretary Rajesh Bhushan together with Member (Health), NITI Aayog Vinod Ok Paul had chaired a high-level video convention assembly on Sunday with all of the states and UTs. The focus of the meet was on COVID-19 Containment & Management in peri-urban, rural and tribal areas together with the Effective Clinical Management of COVID, together with the black Mucor-mycosis fungi which is being recorded in a rising variety of states. 

The assembly was held as the agricultural hinterland of the nation recording a really excessive variety of circumstances with growing fatality and positivity fee, mixed with low reported ranges of testing.

Meanwhile, India’s combat in opposition to the coronavirus goes to get stronger because the nation will likely be releasing the first batch of the anti-COVID-19 drug 2-deoxy-D-glucose (2-DG) on Monday. It will likely be launched by Defence Minister Rajnath Singh.

The 2-DG drug has been developed by DRDO’s Institute of Nuclear Medicine and Allied Sciences (INMAS) in collaboration with Dr Reddy`s Laboratories. 

Clinical trial outcomes have proven that this molecule helps in sooner restoration of hospitalised sufferers and reduces supplemental oxygen dependence and that the upper proportion of sufferers handled with 2-DG confirmed RT-PCR unfavorable conversion in COVID-19 sufferers. 
 

Live TV